P.405 Clinical characteristics and ethnic differences in anti-fibrillarin positive systemic sclerosis patients: an international multicenter cohort study
Roberto D’Alessandro(Hôpital Cochin), Yannick Allanore(Hôpital Cochin), Adrianne Woods(Johns Hopkins University), P. Rubortone(Agostino Gemelli University Polyclinic), Emmanuel Chatelus(Laboratoire National de Référence), A Collet(Université de Lille), Loïc Raffray(Centre National de la Recherche Scientifique), Elisabetta Zanatta(University of Padua), Alexandre Le Joncour(Sorbonne Université), Iván Castellví Barranco(Hospital de Sant Pau), Cristiana Sieiro Santos(Complejo Asistencial Universitario de Palencia), Ami Shah(Johns Hopkins University), Silvia Bellando Randone(Azienda Ospedaliero-Universitaria Careggi), L Hummers(Johns Hopkins University), V Codullo(Policlinico San Matteo Fondazione), Alain Lescoat(Université Rennes 2), Gonzalo Boleto(Sociedade Portuguesa de Cardiologia), Paolo Airo’(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Francesco Del Galdo(NIHR Leeds Musculoskeletal Biomedical Research Unit), David Launay(Inserm), Christopher P. Denton(University College London), Jerome Avouac(Hôpital Cochin), Marie-Elise Truchetet(Centre Hospitalier Universitaire de Bordeaux), Alix Calot(Hôpital Cochin), Stefano Rodolfi(Royal Free London NHS Foundation Trust), Patrice Cacoub(Sorbonne Université), Corrado Campochiaro(Vita-Salute San Raffaele University)
Cited by 0
Related Papers
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
|Immunity|2015|223
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207